Conventional and extended-release etodolac for postsurgical dental pain

Area of Science:

• Pharmacology
• Pain Management
• Clinical Trials

Background:

• Postoperative pain, particularly after dental surgery, requires effective and well-tolerated analgesics.
• Current treatments include conventional etodolac, but prolonged pain relief remains a challenge.

Purpose of the Study:

• To compare the analgesic efficacy and tolerability of a single 1200-mg dose of extended-release etodolac with other etodolac formulations and placebo.
• To evaluate the duration and onset of analgesic action for extended-release etodolac.

Main Methods:

• A double-masked, parallel-group, randomized study involving 237 patients with moderate to severe postoperative pain.
• Comparison of single 1200-mg extended-release etodolac dose against 400-mg extended-release etodolac, 200-mg and 400-mg conventional etodolac (twice-daily), and placebo.
• Pain assessment based on analgesic efficacy and tolerability over time.

Main Results:

• Both conventional etodolac doses and 1200-mg extended-release etodolac were significantly more effective than placebo.
• Conventional etodolac provided 5-6 hours of analgesia, while 1200-mg extended-release etodolac offered 12-24 hours of pain relief.
• 1200-mg extended-release etodolac showed superior efficacy from 6 to 12 hours post-administration; no serious adverse events were reported.

Conclusions:

• Single 1200-mg extended-release etodolac provides prolonged analgesia in the oral surgery pain model.
• The extended-release formulation demonstrates an acceptable side-effect profile, suggesting its potential as an effective option for postoperative pain management.